• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cholecalciferol level and its impact on COVID-19 patients.胆钙化醇水平及其对新冠肺炎患者的影响。
Egypt J Intern Med. 2022;34(1):23. doi: 10.1186/s43162-022-00116-w. Epub 2022 Feb 21.
2
A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.一项评估胆钙化醇补充对桥本甲状腺炎自身免疫可能作用的前瞻性研究。
J Assoc Physicians India. 2023 Jan;71(1):1.
3
[Effect of vitamin D on the severity and prognosis of patients with sepsis: a prospective randomized double-blind placebo study].维生素D对脓毒症患者严重程度及预后的影响:一项前瞻性随机双盲安慰剂研究
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Feb;29(2):106-110. doi: 10.3760/cma.j.issn.2095-4352.2017.02.003.
4
Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.一项随机临床试验:单次高剂量维生素 D3 对中重度 COVID-19 患者住院时间的影响。
JAMA. 2021 Mar 16;325(11):1053-1060. doi: 10.1001/jama.2020.26848.
5
Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.甲基强的松龙输注与地塞米松在新型冠状病毒肺炎急性呼吸窘迫综合征机械通气患者中的比较。
Egypt J Intern Med. 2022;34(1):19. doi: 10.1186/s43162-022-00113-z. Epub 2022 Feb 15.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Vitamin D levels in Swiss breast cancer survivors.瑞士乳腺癌幸存者的维生素D水平
Swiss Med Wkly. 2018 Jan 16;148:w14576. doi: 10.4414/smw.2018.14576. eCollection 2018.
8
Effect of a Single High-Dose Vitamin D3 on the Length of Hospital Stay of Severely 25-Hydroxyvitamin D-Deficient Patients with COVID-19.单剂量高剂量维生素 D3 对 COVID-19 重度 25-羟维生素 D 缺乏症患者住院时间的影响。
Clinics (Sao Paulo). 2021 Nov 26;76:e3549. doi: 10.6061/clinics/2021/e3549. eCollection 2021.
9
Vitamin D supplementation for the treatment of COVID-19: a living systematic review.维生素 D 补充剂治疗 COVID-19:一项正在进行的系统评价。
Cochrane Database Syst Rev. 2021 May 24;5(5):CD015043. doi: 10.1002/14651858.CD015043.
10
High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.COVID-19 老年患者大剂量与标准剂量维生素 D 补充治疗的疗效比较(COVIT-TRIAL):一项多中心、开放标签、随机对照优效性试验
PLoS Med. 2022 May 31;19(5):e1003999. doi: 10.1371/journal.pmed.1003999. eCollection 2022 May.

引用本文的文献

1
The critical impacts of cytokine storms in respiratory disorders.细胞因子风暴在呼吸系统疾病中的关键影响。
Heliyon. 2024 Apr 17;10(9):e29769. doi: 10.1016/j.heliyon.2024.e29769. eCollection 2024 May 15.
2
Determining the Health Problems Experienced by Young Adults in Turkey, Who Received the COVID-19 Vaccine.确定在土耳其接种了新冠疫苗的年轻人所经历的健康问题。
Vaccines (Basel). 2022 Sep 14;10(9):1526. doi: 10.3390/vaccines10091526.
3
The impact of immune dysfunction on perioperative complications in surgical COVID-19 patients: an imperative for early immunonutrition.免疫功能障碍对COVID-19手术患者围手术期并发症的影响:早期免疫营养的必要性。
Patient Saf Surg. 2022 Apr 1;16(1):14. doi: 10.1186/s13037-022-00323-y.

本文引用的文献

1
Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials.维生素 D 补充剂预防急性呼吸道感染:随机对照试验汇总数据的系统评价和荟萃分析。
Lancet Diabetes Endocrinol. 2021 May;9(5):276-292. doi: 10.1016/S2213-8587(21)00051-6. Epub 2021 Mar 30.
2
Interleukin-6 blocking agents for treating COVID-19: a living systematic review.白细胞介素 6 阻断剂治疗 COVID-19:一项实时系统评价。
Cochrane Database Syst Rev. 2021 Mar 18;3(3):CD013881. doi: 10.1002/14651858.CD013881.
3
COVID-19 and IL-6: Why vitamin D (probably) helps but tocilizumab might not.COVID-19 和白细胞介素-6:为什么维生素 D(可能)有帮助,但托珠单抗可能没有。
Eur J Pharmacol. 2021 May 15;899:174031. doi: 10.1016/j.ejphar.2021.174031. Epub 2021 Mar 13.
4
Association of Vitamin D Status With Hospital Morbidity and Mortality in Adult Hospitalized Patients With COVID-19.维生素D状态与成人COVID-19住院患者医院发病率和死亡率的关联
Endocr Pract. 2021 Apr;27(4):271-278. doi: 10.1016/j.eprac.2021.02.013. Epub 2021 Mar 9.
5
Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.一项随机临床试验:单次高剂量维生素 D3 对中重度 COVID-19 患者住院时间的影响。
JAMA. 2021 Mar 16;325(11):1053-1060. doi: 10.1001/jama.2020.26848.
6
Metabolic Healthy Obesity, Vitamin D Status, and Risk of COVID-19.代谢健康型肥胖、维生素D状态与新型冠状病毒肺炎风险
Aging Dis. 2021 Feb 1;12(1):61-71. doi: 10.14336/AD.2020.1108. eCollection 2021 Feb.
7
Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease.维生素 D 缺乏与 COVID-19 阳性和疾病严重程度有关。
J Med Virol. 2021 May;93(5):2992-2999. doi: 10.1002/jmv.26832. Epub 2021 Feb 9.
8
Vitamin D to prevent COVID-19: recommendations for the design of clinical trials.维生素 D 预防 COVID-19:临床试验设计建议。
FEBS J. 2020 Sep;287(17):3689-3692. doi: 10.1111/febs.15534.
9
Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests.意大利一家养老院在 COVID-19 大流行期间的死亡率:与性别、年龄、ADL、维生素 D 补充剂和诊断测试限制的相关性。
Aging (Albany NY). 2020 Dec 22;12(24):24522-24534. doi: 10.18632/aging.202307.
10
Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality.入院时血清 25(OH)D 水平与 COVID-19 分期和死亡率相关。
Am J Clin Pathol. 2021 Feb 11;155(3):381-388. doi: 10.1093/ajcp/aqaa252.

胆钙化醇水平及其对新冠肺炎患者的影响。

Cholecalciferol level and its impact on COVID-19 patients.

作者信息

Saeed Mohammed Abdel Monem, Mohamed Alaa Hussein, Owaynat Ahmed Hassan

机构信息

Critical Care Medicine Department, Faculty of Medicine Helwan University, Helwan, Egypt.

Clinical Pharmacy Department, Helwan University Hospitals, Helwan, Egypt.

出版信息

Egypt J Intern Med. 2022;34(1):23. doi: 10.1186/s43162-022-00116-w. Epub 2022 Feb 21.

DOI:10.1186/s43162-022-00116-w
PMID:35221663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8860261/
Abstract

BACKGROUND

Cholecalciferol is an important nutrient and essential to build body, maintain strong bones, and improves immunity.The main source for vitamin D is the body's skin which absorbs the sun's ultraviolet rays and convert them into vitamin D; at the same time, deficiency can occur or people may not get enough supplementation; this occurs mainly in old age, not taking healthy food, or have darker skin, and this deficient cases can raise the risk of severe COVID-19 if infected.Vitamin D boosts immunity and decreases inflammation. Poorer outcome of corona virus-disease (COVID-19) has been suggested to be due to vitamin D deficiency.We suggested to find the effect of cholecalciferol levels 25-hydroxy vitamin D (25 OHD) on the severity and mortality in patients suffering from COVID-19.

METHODS

Our study is a prospective following of 414 patients admitted in Helwan University Hospitals in the period of June 2020 till October 2021 for severely symptomatic. COVID-19 patients with median of age 54.55 ± 14.27, with a definite range of APACHE II score ranging from 15 to 19 where we measured vitamin D level (cholecalciferol level), correlating the assay level to the inflammatory cytokine storm markers on admission, on the fifth day and after 10 days also the level of vitamin D was correlated to the length of stay mechanical ventilation days and mortality.

RESULTS

Lower level of vitamin D on admission was strongly evident in patients with severely symptomatic and in mortality of COVID-19 patients 58.25 ± 24.59 nmol/L when compared with patients who survived 103.97 ± 36.14 nmol/L with value < 0.001.Also, when correlating the initial level of vitamin D on admission with the level of the inflammatory cytokine storm markers on admission, on fifth day from admission and on the tenth day, it shows a strong inverse correlation between vitamin D level on admission and ferritin level on fifth day ρ-0.739 value < 0.001 also on the tenth day ρ-0.885, value < 0.001, in comparing also with D-dimer on fifth day ρ-0.858, value < 0.001 also showing a strong inverse correlation with a highly significant value this also evident on the D-dimer level on the tenth day ρ-0.889 with value < 0.001, CRP at fifth and tenth day ρ-0.868, value < 0.001, ρ-0.891, value < 0.001 respectively also in correlating the LDH level on the fifth and tenth day with the initial level of vitamin D it shows a strong inverse correlation with a highly significant value. ρ-0.887, value < 0.001, ρ-0.878, value < 0.001 respectively, in the fifth and tenth day. Neutrophil to lymphocyte ratio was strongly, inversely correlated to the vitamin D level (cholecalciferol) on admission with ρ-0.753, < 0.001, ρ-0.882, < 0.001 respectively. Also, chest computed tomography in the fifth and tenth day of admission showed a very strong inverse correlation with vitamin D level and a highly significant statistical difference ρ-0.655, value < 0.001 respectively.Length of stay and mechanical ventilation days were also strongly inversely correlated to the cholecalciferol level ρ-0.795, < 0.001, ρ- 0.879, < 0.001 ROC curve of vitamin D to predict mortality (RR 0.865, 95% CI 0.828-0.896, < 0.001, with cut off-value for vit. D < 60 nmol/L, regardless of other factors like age, gender, and presence of other co-morbidities.

CONCLUSION

Low level of cholecalciferol was strongly inversely correlated with cytokine storm markers and independent predictor of severity and mortality in COVID-19 patients.

摘要

背景

胆钙化醇是一种重要营养素,对身体发育、维持骨骼强健及提高免疫力至关重要。维生素D的主要来源是人体皮肤,其吸收太阳紫外线并将其转化为维生素D;同时,可能会出现维生素D缺乏或人们补充不足的情况;这主要发生在老年人、未摄入健康食物或皮肤较黑的人群中,而这种缺乏情况若感染新冠病毒,会增加患重症COVID-19的风险。维生素D可增强免疫力并减轻炎症。有研究表明,冠状病毒病(COVID-19)预后较差可能与维生素D缺乏有关。我们建议研究25-羟基维生素D(25 OHD)水平的胆钙化醇对COVID-19患者病情严重程度和死亡率的影响。

方法

我们的研究是对2020年6月至2021年10月期间在赫尔万大学医院收治的414例有严重症状的患者进行前瞻性随访。这些COVID-19患者的年龄中位数为54.55±14.27岁,急性生理与慢性健康状况评分系统(APACHE II)评分为15至19分,我们测量了维生素D水平(胆钙化醇水平),将检测水平与入院时、第5天和10天后的炎症细胞因子风暴标志物进行关联,同时将维生素D水平与机械通气天数和住院时间以及死亡率进行关联。

结果

与存活患者的103.97±36.14 nmol/L相比,有严重症状的COVID-19患者入院时维生素D水平较低,为58.25±24.59 nmol/L,P值<0.001。此外,将入院时维生素D的初始水平与入院时、入院第5天和第10天的炎症细胞因子风暴标志物水平进行关联时,结果显示入院时维生素D水平与第5天铁蛋白水平呈强烈负相关,ρ=-0.739,P值<0.001,第10天时ρ=-0.885,P值<0.001;与第5天D-二聚体相比,ρ=-0.858,P值<0.001,也显示出强烈负相关且具有高度显著性P值,第10天D-二聚体水平ρ=-0.889,P值<0.001;第5天和第10天的C反应蛋白(CRP)分别为ρ=-0.868,P值<0.001,ρ=-0.891,P值<0.001;将第第5天和第10天的乳酸脱氢酶(LDH)水平与维生素D的初始水平进行关联时,也显示出强烈负相关且具有高度显著性P值,第5天和第10天分别为ρ=-0.887,P值<0.001,ρ=-0.878,P值<0.001。中性粒细胞与淋巴细胞比值与入院时维生素D水平(胆钙化醇)呈强烈负相关,分别为ρ=-0.753,P<0.001,ρ=-0.882,P<0.001。此外,入院第5天和第10天的胸部计算机断层扫描显示与维生素D水平呈非常强烈的负相关且具有高度显著的统计学差异,分别为ρ=-0.655,P值<0.001。住院时间和机械通气天数也与胆钙化醇水平呈强烈负相关,ρ=-0.795,P<0.001,ρ=-0.879,P<0.001。维生素D预测死亡率的ROC曲线(风险比0.865,95%置信区间0.828-0.896,P<0.001),维生素D临界值<60 nmol/L,不受年龄、性别和其他合并症等其他因素影响。

结论

胆钙化醇水平低与细胞因子风暴标志物呈强烈负相关,是COVID-19患者病情严重程度和死亡率的独立预测指标。